Showing results (151-160 of 261) with videos related to
Sort By:
Pageof 27
Japanese Journal of Clinical Oncology|May 10, 2019
Phase II trial of S-1 plus cisplatin combined with bevacizumab for advanced non-squamous non-small cell lung cancer (TCOG LC-1202)Akihiko Miyanaga, Kaoru Kubota, Yukio Hosomi, et al.Respiratory Investigation|September 1, 2020
Serum KL-6 level is a useful biomarker for evaluating the severity of coronavirus disease 2019Nobuyasu Awano, Minoru Inomata, Naoyuki Kuse, et al.Drug Discoveries & Therapeutics|June 26, 2022
Efficacy and safety of sotrovimab for vaccinated or unvaccinated patients with mild-to-moderate COVID-19 in the omicron eraTakehiro Izumo, Nobuyasu Awano, Naoyuki Kuse, et al.Internal Medicine (Tokyo, Japan)|April 4, 2022
Unilateral Autoimmune Pulmonary Alveolar Proteinosis with Polymyositis-related Interstitial Lung DiseaseYutaka Muto, Eri Hagiwara, Tomohisa Baba, et al.Anticancer Research|May 27, 2026
The Association Between Longitudinal Changes in TRACP-5b and Bone Metastasis Progression During Osimertinib TherapyKeisuke Ikegami, Reiko Ando Makihara, Yuki Shinno, et al.Allergology International : Official Journal of the Japanese Society of Allergology|February 27, 2019
Sublingual administration of liposomes enclosing alpha-galactosylceramide as an effective adjuvant of allergen immunotherapy in a murine model of allergic rhinitisSatoshi Suzuki, Daiju Sakurai, Toshioki Sakurai, et al.Clinical Lung Cancer|February 27, 2024
Artemis: A Multicenter, Open-Label, Single-Arm, Phase II Study to Evaluate the Efficacy and Safety of First-Line Carboplatin/Paclitaxel/Lenvatinib/Pembrolizumab Combination for Previously Untreated Advanced or Recurrent Thymic CarcinomasYusuke Okuma, Shogo Nomura, Jun Sakakibara-Konishi, et al.Japanese Journal of Clinical Oncology|January 3, 2022
Performance of Japanese patients in registrational studiesYasushi Goto, Sayaka Arakawa, Masayuki Shirasawa, et al.Clinical Lung Cancer|July 30, 2024
Impact of Durvalumab on the Duration and Complexity of Corticosteroid Therapy for Pneumonitis After ChemoradiotherapySaori Murata, Hidehito Horinouchi, Momoko Morishita, et al.Clinical Lung Cancer|February 15, 2024
Efficacy of Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Metastatic Non-Small Cell Lung Cancer Patients with Poor Performance Status and Epidermal Growth Factor Receptor Mutations: Findings from the Japanese Lung Cancer Registry DatabaseYusuke Okuma, Yasushi Shintani, Ikuo Sekine, et al.Pageof 27